サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1654161

急性反復性発作の市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2025年～2030年

Acute Repetitive Seizures Market Size, Share & Trends Analysis Report By Product (USL-261, NRL-1, AZ-002, Diastat Rectal Gel), By Region (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) And Segment Forecasts, 2025 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
急性反復性発作の市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2025年～2030年
出版日: 2025年01月03日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

急性反復性発作市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の急性反復性発作市場規模は2030年までに64億8,000万米ドルに達し、2025～2030年のCAGRは12.7%で拡大すると推定されています。

てんかんに関する認知度を高める取り組みの増加が市場を牽引する主要要因です。

市場は現在、主に経口ベンゾジアゼピン（ジアゼパムとロラゼパム）を含むジェネリック医薬品が牽引しています。米国では直腸用ジアゼパムが、EUでは頬用ミダゾラムが唯一承認されています。その他の薬剤、例えばジアゼパム（経口と筋肉内）、ミダゾラム（頬側、鼻腔内、筋肉内）、ロラゼパム（経口、鼻腔内、舌下）、プロゲステロンなどは、主に適応外で使用されています。同市場は少数の大手企業で固められ、高い市場シェアが見込まれます。

さらに、医療支出を抑制するため、各国政府はクリニックや在宅医療などの外来治療モデルを通じて入院期間や現場での治療費を削減する努力を続けています。インドや中国のような新興国は、このような医療改革をますます実施しており、急性反復性発作市場の成長を促進すると期待されています。

薬剤投与にはいくつかの経路があるが、その中でも経鼻経路は、頬側、直腸、非経口といった他の経路よりも最も好まれています。頬側からの投与は、病院外でも投薬が可能であるため、小児発作に悩む幼児の介護者や親に好まれています。

急性反復性発作市場レポートハイライト

  • 世界の急性反復性発作市場規模は2024年に31億5,000万米ドルと推定され、予測期間中のCAGRは12.7%と予測されます。
  • USL-261が市場を独占し、2024年には44.5%のシェアを占めました。これは、迅速な発作制御を目的とした経鼻治療としての有効性による。
  • 北米の急性反復性発作市場は、2024年の売上高シェア43.0％で世界市場を独占しました。同地域の市場成長の原動力は、てんかんと神経疾患の有病率の高さであり、強固な医療インフラがそれを補完しています。
  • 日本の急性反復性発作市場は、2024年にアジア太平洋の急性反復性発作市場を独占しました。人口の高齢化と神経疾患に対する意識の高まりが、効果的な治療法の需要を刺激しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 急性反復性発作市場の変数、動向、範囲

  • 市場系統の展望
  • 市場力学
    • 市場促進要因分析
    • 市場抑制要因分析
  • ビジネス環境分析
    • 産業分析-ポーターのファイブフォース分析
    • PESTLE分析

第4章 急性反復性発作市場：製品ビジネス分析

  • 製品市場シェア、2024年と2030年
  • 製品セグメントダッシュボード
  • 市場規模と予測と動向分析、製品別、2018～2030年
  • USL-261
  • NRL-1
  • AZ-002
  • ディアスタット直腸ジェル
  • その他

第5章 急性反復性発作市場：地域別、推定・動向分析

  • 地域別市場シェア分析、2024年と2030年
  • 地域別市場ダッシュボード
  • 市場規模、予測動向分析、2018～2030年
  • 北米
    • 国別、2018～2030年
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 国別、2018～2030年
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • デンマーク
    • スウェーデン
  • アジア太平洋
    • 国別、2018～2030年
    • 日本
    • 中国
    • インド
    • 韓国
    • オーストラリア
    • タイ
  • ラテンアメリカ
    • 国別、2018～2030年
    • ブラジル
    • アルゼンチン
  • 中東・アフリカ
    • 国別、2018～2030年
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 参加者概要
  • 企業の市況分析
  • 企業分類
  • 戦略マッピング
  • 企業プロファイル/上場企業
    • UCB SA, Belgium
    • Neurelis, Inc.
    • Bausch Health Companies Inc.
    • Grupo Ferrer Internacional, SA
    • SERB
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. Global acute repetitive seizures market, by region, 2018 - 2030 (USD Million)
  • Table 4. Global acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 5. North America acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
  • Table 6. North America acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 7. U.S. acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 8. Canada acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 9. Mexico acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 10. Europe acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
  • Table 11. Europe acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 12. UK acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 13. Germany acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 14. France acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 15. Italy acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 16. Spain acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 17. Norway acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 18. Denmark acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 19. Sweden acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 20. Asia Pacific acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
  • Table 21. Asia Pacific acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 22. Japan acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 23. China acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 24. India acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 25. Australia acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 26. South Korea acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 27. Thailand acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 28. Latin America acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
  • Table 29. Latin America acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 30. Brazil acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 31. Argentina acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 32. Middle East & Africa Acute repetitive seizures market, by country, 2018 - 2030 (USD Million)
  • Table 33. Middle East & Africa acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 34. South Africa acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 35. Saudi Arabia acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 36. UAE acute repetitive seizures market, by product, 2018 - 2030 (USD Million)
  • Table 37. Kuwait acute repetitive seizures market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Acute repetitive seizures market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product outlook (USD Million)
  • Fig. 10 Competitive landscape
  • Fig. 11 Acute repetitive seizures market dynamics
  • Fig. 12 Acute repetitive seizures market: Porter's five forces analysis
  • Fig. 13 Acute repetitive seizures market: PESTLE analysis
  • Fig. 14 Acute repetitive seizures market: Product segment dashboard
  • Fig. 15 Acute repetitive seizures market: Product market share analysis, 2024 & 2030
  • Fig. 16 USL-261 market, 2018 - 2030 (USD Million)
  • Fig. 17 NRL-1 market, 2018 - 2030 (USD Million)
  • Fig. 18 AZ-002 market, 2018 - 2030 (USD Million)
  • Fig. 19 Diastat rectal gel market, 2018 - 2030 (USD Million)
  • Fig. 20 Others market, 2018 - 2030 (USD Million)
  • Fig. 21 Acute repetitive seizures market revenue, by region
  • Fig. 22 Regional marketplace: Key takeaways
  • Fig. 23 Regional marketplace: Key takeaways
  • Fig. 24 North America acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 25 U.S. country dynamics
  • Fig. 26 U.S. acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 27 Canada country dynamics
  • Fig. 28 Canada acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 29 Mexico country dynamics
  • Fig. 30 Mexico acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 31 Europe acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 32 UK country dynamics
  • Fig. 33 UK acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 34 Germany country dynamics
  • Fig. 35 Germany acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 36 France country dynamics
  • Fig. 37 France acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 38 Italy country dynamics
  • Fig. 39 Italy acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 40 Spain country dynamics
  • Fig. 41 Spain acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 42 Norway country dynamics
  • Fig. 43 Norway acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 44 Sweden country dynamics
  • Fig. 45 Sweden acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 46 Denmark country dynamics
  • Fig. 47 Denmark acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 48 Asia Pacific acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 49 Japan country dynamics
  • Fig. 50 Japan acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 51 China country dynamics
  • Fig. 52 China acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 53 India country dynamics
  • Fig. 54 India acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 55 Australia country dynamics
  • Fig. 56 Australia acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 57 South Korea country dynamics
  • Fig. 58 South Korea acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 59 Thailand country dynamics
  • Fig. 60 Thailand acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 61 Latin America acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 62 Brazil country dynamics
  • Fig. 63 Brazil acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 64 Argentina country dynamics
  • Fig. 65 Argentina acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 66 MEA acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 67 South Africa country dynamics
  • Fig. 68 South Africa acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 69 Saudi Arabia country dynamics
  • Fig. 70 Saudi Arabia acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 71 UAE country dynamics
  • Fig. 72 UAE acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 73 Kuwait country dynamics
  • Fig. 74 Kuwait acute repetitive seizures market, 2018 - 2030 (USD Million)
  • Fig. 75 Company categorization
  • Fig. 76 Company market position analysis
  • Fig. 77 Strategic framework
目次
Product Code: GVR-2-68038-489-5

Acute Repetitive Seizures Market Growth & Trends:

The global acute repetitive seizures market size is estimated to reach USD 6.48 billion by 2030, expanding at a CAGR of 12.7% from 2025 to 2030, according to a new report by Grand View Research, Inc. Rise in the number of initiatives to increase awareness about epilepsy is the major factor driving the market.

The market is currently led by generic drugs which mainly include oral benzodiazepines (diazepam and lorazepam). Rectal diazepam is the only approved drug for use in U.S. and buccal midazolam in the European Union. Other drugs, such as diazepam (oral and intramuscular), midazolam (buccal, intranasal, intramuscular), lorazepam (oral, intranasal, sublingual), and progesterone are majorly used off label. The market is expected to be consolidated with a few major companies and a high market share.

Furthermore, in an attempt to curb healthcare expenditure, governments are making continuous efforts to reduce hospital stays and on-site treatment costs via outpatient care models, such as clinic and home healthcare. Emerging economies like India and China, are increasingly implementing such healthcare reform, which is expected to propel the growth of acute repetitive seizures market.

There are several routes of drug administration; out of which, the nasal route is the most preferred over others, such as buccal, rectal, and parenteral. The buccal route is preferred by caregivers and parents for children suffering from pediatric seizures since medication can be administered even outside the hospital.

Acute Repetitive Seizures Market Report Highlights:

  • Global acute repetitive seizures market size was estimated at USD 3.15 billion in 2024 and is expected to register a CAGR of 12.7% over the forecast period
  • USL-261 dominated the market and accounted for a share of 44.5% in 2024, owing to its effectiveness as an intranasal treatment aimed at achieving rapid seizure control.
  • North America acute repetitive seizures market dominated the global market with a revenue share of 43.0% in 2024. Market growth in the region is driven by a high prevalence of epilepsy and neurological disorders, complemented by a robust healthcare infrastructure.
  • The acute repetitive seizures market in Japan dominated the Asia Pacific acute repetitive seizures market in 2024. The aging population, coupled with rising awareness of neurological disorders, stimulates demand for effective therapies.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Acute Repetitive Seizures Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Acute Repetitive Seizures Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. USL-261
    • 4.4.1. USL-261 Market, 2018 - 2030 (USD Million)
  • 4.5. NRL-1
    • 4.5.1. NRL-1 Market, 2018 - 2030 (USD Million)
  • 4.6. AZ-002
    • 4.6.1. AZ-002 Market, 2018 - 2030 (USD Million)
  • 4.7. Diastat Rectal Gel
    • 4.7.1. Diastat Rectal Gel Market, 2018 - 2030 (USD Million)
  • 4.8. Others
    • 4.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Acute Repetitive Seizures Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Market Share Analysis, 2024 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 5.4. North America
    • 5.4.1. North America Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.4.2. U.S.
      • 5.4.2.1. Key Country Dynamics
      • 5.4.2.2. Regulatory Framework
      • 5.4.2.3. Competitive Insights
      • 5.4.2.4. U.S. Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.4.3. Canada
      • 5.4.3.1. Key Country Dynamics
      • 5.4.3.2. Regulatory Framework
      • 5.4.3.3. Competitive Insights
      • 5.4.3.4. Canada Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.4.4. Mexico
      • 5.4.4.1. Key Country Dynamics
      • 5.4.4.2. Regulatory Framework
      • 5.4.4.3. Competitive Insights
      • 5.4.4.4. Mexico Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Europe
    • 5.5.1. Europe Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.5.2. UK
      • 5.5.2.1. Key Country Dynamics
      • 5.5.2.2. Regulatory Framework
      • 5.5.2.3. Competitive Insights
      • 5.5.2.4. UK Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.3. Germany
      • 5.5.3.1. Key Country Dynamics
      • 5.5.3.2. Regulatory Framework
      • 5.5.3.3. Competitive Insights
      • 5.5.3.4. Germany Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.4. France
      • 5.5.4.1. Key Country Dynamics
      • 5.5.4.2. Regulatory Framework
      • 5.5.4.3. Competitive Insights
      • 5.5.4.4. France Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.5. Italy
      • 5.5.5.1. Key Country Dynamics
      • 5.5.5.2. Regulatory Framework
      • 5.5.5.3. Competitive Insights
      • 5.5.5.4. Italy Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.6. Spain
      • 5.5.6.1. Key Country Dynamics
      • 5.5.6.2. Regulatory Framework
      • 5.5.6.3. Competitive Insights
      • 5.5.6.4. Spain Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.7. Norway
      • 5.5.7.1. Key Country Dynamics
      • 5.5.7.2. Regulatory Framework
      • 5.5.7.3. Competitive Insights
      • 5.5.7.4. Norway Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.8. Denmark
      • 5.5.8.1. Key Country Dynamics
      • 5.5.8.2. Regulatory Framework
      • 5.5.8.3. Competitive Insights
      • 5.5.8.4. Denmark Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.5.9. Sweden
      • 5.5.9.1. Key Country Dynamics
      • 5.5.9.2. Regulatory Framework
      • 5.5.9.3. Competitive Insights
      • 5.5.9.4. Sweden Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Asia Pacific
    • 5.6.1. Asia Pacific Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.6.2. Japan
      • 5.6.2.1. Key Country Dynamics
      • 5.6.2.2. Regulatory Framework
      • 5.6.2.3. Competitive Insights
      • 5.6.2.4. Japan Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.6.3. China
      • 5.6.3.1. Key Country Dynamics
      • 5.6.3.2. Regulatory Framework
      • 5.6.3.3. Competitive Insights
      • 5.6.3.4. China Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.6.4. India
      • 5.6.4.1. Key Country Dynamics
      • 5.6.4.2. Regulatory Framework
      • 5.6.4.3. Competitive Insights
      • 5.6.4.4. India Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.6.5. South Korea
      • 5.6.5.1. Key Country Dynamics
      • 5.6.5.2. Regulatory Framework
      • 5.6.5.3. Competitive Insights
      • 5.6.5.4. South Korea Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.6.6. Australia
      • 5.6.6.1. Key Country Dynamics
      • 5.6.6.2. Regulatory Framework
      • 5.6.6.3. Competitive Insights
      • 5.6.6.4. Australia Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.6.7. Thailand
      • 5.6.7.1. Key Country Dynamics
      • 5.6.7.2. Regulatory Framework
      • 5.6.7.3. Competitive Insights
      • 5.6.7.4. Thailand Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Latin America
    • 5.7.1. Latin America Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.7.2. Brazil
      • 5.7.2.1. Key Country Dynamics
      • 5.7.2.2. Regulatory Framework
      • 5.7.2.3. Competitive Insights
      • 5.7.2.4. Brazil Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.7.3. Argentina
      • 5.7.3.1. Key Country Dynamics
      • 5.7.3.2. Regulatory Framework
      • 5.7.3.3. Competitive Insights
      • 5.7.3.4. Argentina Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 5.8. MEA
    • 5.8.1. MEA Acute Repetitive Seizures Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 5.8.2. South Africa
      • 5.8.2.1. Key Country Dynamics
      • 5.8.2.2. Regulatory Framework
      • 5.8.2.3. Competitive Insights
      • 5.8.2.4. South Africa Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.8.3. Saudi Arabia
      • 5.8.3.1. Key Country Dynamics
      • 5.8.3.2. Regulatory Framework
      • 5.8.3.3. Competitive Insights
      • 5.8.3.4. Saudi Arabia Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.8.4. UAE
      • 5.8.4.1. Key Country Dynamics
      • 5.8.4.2. Regulatory Framework
      • 5.8.4.3. Competitive Insights
      • 5.8.4.4. UAE Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 5.8.5. Kuwait
      • 5.8.5.1. Key Country Dynamics
      • 5.8.5.2. Regulatory Framework
      • 5.8.5.3. Competitive Insights
      • 5.8.5.4. Kuwait Acute Repetitive Seizures Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Participant Overview
  • 6.2. Company Market Position Analysis
  • 6.3. Company Categorization
  • 6.4. Strategy Mapping
  • 6.5. Company Profiles/Listing
    • 6.5.1. UCB S.A., Belgium
      • 6.5.1.1. Overview
      • 6.5.1.2. Financial Performance
      • 6.5.1.3. Product Benchmarking
      • 6.5.1.4. Strategic Initiatives
    • 6.5.2. Neurelis, Inc.
      • 6.5.2.1. Overview
      • 6.5.2.2. Financial Performance
      • 6.5.2.3. Product Benchmarking
      • 6.5.2.4. Strategic Initiatives
    • 6.5.3. Bausch Health Companies Inc.
      • 6.5.3.1. Overview
      • 6.5.3.2. Financial Performance
      • 6.5.3.3. Product Benchmarking
      • 6.5.3.4. Strategic Initiatives
    • 6.5.4. Grupo Ferrer Internacional, S.A.
      • 6.5.4.1. Overview
      • 6.5.4.2. Financial Performance
      • 6.5.4.3. Product Benchmarking
      • 6.5.4.4. Strategic Initiatives
    • 6.5.5. SERB
      • 6.5.5.1. Overview
      • 6.5.5.2. Financial Performance
      • 6.5.5.3. Product Benchmarking
      • 6.5.5.4. Strategic Initiatives